In addition to its heat-stable and heat-labile enterotoxins, Escherichia coli has been reported to produce another toxin which has enterotoxic activity. This toxin, referred to either as Verotoxin or Shigella dysenteriae 1 (Shiga)-like toxin (SLT), was first described in 1977 by Konowalchuk et al. (11) . Like Shiga toxin, the SLT of E. coli is enterotoxic for ligated rabbit ileal loops, paralytic and lethal for mice, and cytotoxic for selected cell lines in vitro (18) . The cytotoxicity of SLT is also neutralized by polyclonal antiserum against Shiga toxin (20) . SLT contains one A subunit and several copies of a B subunit (18) . However, the function of each subunit of SLT has not been directly demonstrated. Studies with the prototype Shiga toxin (4, 23) indicate that its A subunit contains the biologically active portion of the toxin while its B subunit contains binding component(s). The SLT of E. coli has been implicated as a possible virulence factor in the pathogenesis of certain diarrheal diseases (3, 27, 28, 32) , hemorrhagic colitis (12, 13, 21, 25) , and hemolytic uremic syndrome (10, 29) . However, collection of epidemiological data on the association of SLT production with disease has been hampered by the fact that the methods currently available for screening of E. coli for SLT are expensive, time consuming, and labor intensive. Moreover, attempts to develop immunochemical tests to detect toxinproducing bacteria in our laboratory have been hampered by the presence of cross-reacting antibacterial antibodies in polyclonal antitoxin and normal sera. The use of monoclonal antibodies rather than polyclonal antisera should improve the specificity of immunochemical tests for the detection of SLT.
Monoclonal antibodies have been produced against the heat-stable enterotoxin of E. coli (2) , heat-labile toxin of E. coli (1) , cholera toxin from V. cholerae (9, 15, 24, 26) , and Shiga toxin from Shigella dysenteriae type 1 (4, 8) . These * Corresponding author. monoclonal antibodies have been helpful in crossneutralization studies, epitope-mapping experiments, and in the development of rapid diagnostic tests for the presence of various antigens in patient and food samples. In this paper, we describe the production and characterization of three monoclonal antibodies against SLT and the successful use of one of these antibodies in the development of an assay to detect high-SLT-producing bacteria growing on agar plates. Toxin purification. Shiga toxin from Shigella dysenteriae type 1 strain 60R and SLT from E. coli H30 were prepared and purified by published techniques (18, 19) .
MATERIALS AND METHODS
Production and purification of monoclonal antibodies. BALB/c mice (female, 6 to 8 weeks old) were immunized with purified, biologically active SLT from E. coli H30. The mice were periodically bled from the orbital plexus to assess the titers of neutralizing antibody. Four mice were immunized with 0.4 to 1.6 ,ug of purified toxin on days 1, 37, 54, 83, and 101. The toxin was administered intraperitoneally in 2. Cell fusion with splenocytes and SP2/0-Ag 14 myeloma cells, selection, and growth of hybrids were performed as described previously (16) . Cell culture supernatants were screened for toxin-specific antibodies by a cytotoxin neutralization assay with purified E. coli H30 toxin as previously described (6) . Positive hybrids were subcloned twice by limiting dilution at 1 and 0.1 cells per well and retested for antibody production by neutralization. Isotypes were determined by immunodiffusion with class-specific antisera (Litton Bionetics, Kensington, Md.).
Assays with monoclonal antibodies were performed with either unconcentrated or concentrated culture supernatants. Concentrated culture supernatants were prepared by precipitation with 50% saturated ammonium sulfate (pH 7.0) followed by dialysis against 0.1 M phosphate buffer (pH 7.4).
Immunoprecipitation of SLT by monoclonal antibodies. Immunoprecipitation of toxin-monoclonal antibody complexes with Staphylococcus aureus was performed as described previously (30) . Radioiodination of purified SLT from E. coli H30 was performed by the chloramine T method by published procedures (18) . Proteins immunoprecipitated by the monoclonal antibodies were resolved by electrophoresis on sodium dodecyl sulfate-15% polyacrylamide gels (14) and identified by fluorography in the presence of XOmatic regular intensifying screens (Eastman Kodak Company, Rochester, N.Y.).
Immunoblot analysis of monoclonal antibodies. Purified SLT from E. coli H30 was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with 15% acrylamide gels (approximately 50 ,ug of toxin per gel) (14) . When electrophoresis was completed, the gels were removed, and the separated toxin subunits were electrophoretically transferred to nitrocellulose paper (pore size, 0.45 ,um; BA 85; Schleicher & Schuell, Inc., Keene, N.H.) BA 85, 0.45 jim) essentially as described by Towbin et al. (31) . The nitrocellulose paper-gel sandwich was electrophoresed overnight under a constant current of 150 mA at 10°C. After electrophoresis, the nitrocellulose paper was stained immunochemically or with amido black (0.1% [wt/vol]). All manipulations of the nitrocellulose paper were done at room temperature. Immunochemical staining was performed by first blocking the paper with 3% (wt/vol) gelatin in Trisbuffered saline (TBS; 20 mM Tris hydrochloride, 500 mM NaCl; pH 7.5) for 30 min and then incubating it with monoclonal antibodies (undiluted culture supernatants). The nitrocellulose paper was then washed with TBS (three 15-min washes with 200 ml of buffer per wash) and subsequently stained for 3 h with horseradish peroxidaseconjugated goat anti-mouse immunoglobulin G (IgG) (whole molecule) (Sigma Chemical Co., St. Louis, Mo.) diluted 1:2,000 in TBS-1% (wt/vol) gelatin. The nitrocellulose paper was washed as described above and developed in TBS containing 0.05% (wt/vol) 4 (5) .
(ii) Cytotoxicity assay for SLT. Sonic lysates at various dilutions or culture supernatants at a 1:100 dilution were tested for cytotoxicity on HeLa cells as previously described (6) . Neutralization of Shiga toxin and SLT was performed by published procedures (6) . Neutralization of the cytotonic effect of heat-labile enterotoxin (LT), LT-like toxin, and cholera toxin for Y-1 adrenal cells was also performed by published procedures (7, 9) .
(iii) Mouse lethality. Ammonium sulfate-concentrated culture supernatants of MAb 16E6 and MAb 32D3 were tested for their ability to neutralize the lethality for mice of purified SLT from E. coli H30. The samples were prepared by using the same antibody and toxin stock solutions used for the enterotoxicity neutralization study. One microgram of toxin was mixed with the undiluted monoclonal antibody solution and incubated as described for the enterotoxicity assay. The neutralized samples were tested for lethality in CD-1 mice (female, 30 to 35 g; Charles River, Kingston, N.Y.) as previously described (22 were then placed on top of the colonies and allowed to absorb moisture from the plates. Bubbles trapped between the nitrocellulose membranes were expressed manually, and 2 ml of polymyxin B solution (2 mg of polymyxin B sulfate [Sigma] per ml in PBS) were layered over the membranes and allowed to permeate the membranes for 45 min at 37°C to release toxin from the bacteria. The liberated toxin was bound by the membrane, and the bacterial debris adhering to the membranes was washed off with TBS (pH 7.5). Identical membranes were prepared for staining with positive and negative monoclonal antibodies. Precautions for infectious material were taken during the blotting and staining procedures since viable organisms had been observed to remain on the plates after the polymyxin B treatment.
After the toxin was released from the bacteria, the blots were stained immunochemically for the presence of SLT. Immunochemical staining was performed as follows: (i) the blots were blocked with 3% (wt/vol) gelatin in TBS for 30 Three hybrid cell lines, designated 16E6, 13C4, and 19G8, were recovered and cloned from two fusions involving the SP2/0-Ag 14 myeloma cell line and spleen cells from BALB/c mice immunized against purified, biologically active SLT from E. coli H30. Approximately 2,000 hybrids were screened from the two fusions. Hybrid cell line 16E6 was isolated from fusion 1, and lines 13C4 and 19G8 were derived from fusion 2.
The limiting factor in the development of monoclonal antibodies against SLT was the availability of purified toxin for immunizations, screening assays, and characterization studies. The purification of SLT routinely took 3 weeks, and the yield of pure toxin from an 8-liter culture was only approximately 200 Rg. Large amounts of toxin were expended in an attempt to develop an enzyme-linked immunosorbant assay for the detection of nonneutralizing antibodies. These efforts were, in practical terms, not successful, due to the need for quantities of toxin that were not feasible for routine screening. The only sensitive and specific assay available in our laboratory for identifying antitoxin antibodies was the neutralization assay which was used as the screening assay for both fusions. Genetic studies are in progress to obtain larger quantities of holotoxin as well as A and B subunits alone. Once available, these reagents should facilitate the production of additional monoclonal antibodies for epitope-mapping studies. Table 1 summarizes the results of the antibody characterization studies. All three antibodies were of the IgGl heavy chain and kappa light chain class. All three antibodies immunoprecipitated the holotoxin (Fig. 1) and neutralized the cytotoxicity of the toxin ( and MAb 13C4 did not neutralize the cytotonic activity of purified cholera toxin, purified LT of porcine or human origin, or LT-like toxin from E. coli. These, neutralization studies confirm earlier observations (20) that Shiga toxin and SLT are antigenically related and that Shigella flexneri, V. parahaemolyticus, V. cholerae, and Salmonella typhimurium produce SLT (17) .
Rapid epidemiologic screening for E. coli strains that produce high levels of SLT. To facilitate the detection of bacteria producing high levels of SLT, a colony blot assay was developed. Two events contributed to the successful development of the colony blot assay. These were (i) the production of SLT-specific monoclonal antibodies and (ii) the observation that subinhibitory concentrations of the antibiotics trimethoprim and sulfamethoxazole increased, the production of toxin for E. coli 933 (H. Karch, A. D. O'Brien, P. Goroncy, and W. Opferkuch, Abstr. Annu. Meet. Am. Soc. Microbiol., 1985. Blll, p. 36). Figure 2 compares the results of colony blot assays performed with monoclonal antibodies and with rabbit polyclonal antisera. SLT in 33 of the 62 different strains tested was detected by MAb 13C4. There was no background staining with MAb 32D3, the negative control antibody (IgGl/kappa) directed against the B subunit of cholera toxin (9) . In cohtrast, SLT in bacterial colonies stained with the polyclonal rabbit sera was not readily discernible due to a high level of background staining by the normal serum. The staining intensity noted among the different strains of bacte- ria tested by using the polyclonal antisera did not correlate with the presence of SLT.
The strains studied in the colony blot assay had previously been tested for the levels of SLT in the sonic lysates using the cytotoxicity assay (L. R (Fig. 3) . All strains classified as high toxin producers were positive in the colony blot assay, while all strains that were classified as low to moderate or trace toxin producers were negative in the blot assay. Twelve of the high toxin producers tested in this study were E. coli of the serotype 0157:H7. All samples of this serotype were categorized as high toxin producers in the cytotoxicity assay, and atll of these were positive in the colony blot assay. Since E. coli 0157:H7 cells have been implicated as etiologic a,gents in'several cases of food-borne hemorrhagic colitis (3, 27, 28, 32) as well as patients with hemolytic uremic syndrome (10, 29) , the detection of these bacteria in patient and food samples is desirable. Where tissue culture facilities are not available or extensive bacteriologic workups are not practical, the colony blot assay may be a useful screening test for the identification of bacteria which make high levels of SLT.
